// App-Quantinova.ai

M2187 2016 AHA : Effectiveness of Rivaroxaban among Patients Diagnosed With Pulmonary Embolism

Researchers

Presenter

  • Onur Baser

Principal Investigators

  • Phil Wells

  • W. Frank Peacock

  • Craig Coleman

  • Gregory J Fermann

  • Jeff Schein

  • Concetta Crivera

Medical Centers

  • Baylor College of Medicine, Houston, TX

  • Univ of Ottawa, Ottawa, Canada

  • University of Cincinnati, Cincinnati, OH

  • Univ of Connecticut, Hartford, CT

  • STATinMED Res, New York, NY

  • STATinMED Research, Plano, TX

Locations

  • United States

  • Canada

Companies

  • JB Medical Ltd.

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Pulmonary embolism

Biomarkers

  • Folate Hydrolase 1

Drug/Treatment

  • Heparin

  • rivaroxaban

  • Warfarin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved